Merck (MRK) reported Q1 FY 2017 earnings of $0.88 per share (versus $0.89 in Q1 FY 2016), beating analysts' consensus estimate of $0.83.
The company's quarterly revenues amounted to $9.434 bln (+1.3% y/y), beating analysts' consensus estimate of $9.254 bln.
MRK rose to $62.61 (+0.37%) in pre-market trading.